Analyse-Recherche-Developpement pour l'INF… SA

Analyse-Recherche-Developpement pour l'INF… reported total assets of €16.3m at the end of the 2025 financial year (annual accounts filed with the NBB on 25 Aug 2026).

By total assets for 2025, Analyse-Recherche-Developpement pour l'INF… ranks among the 20 largest of the 327 companies in its sector (NACE 2110) in Belgium that filed accounts for that financial year. Largest companies in the sector →

Company number (CBE) 0451.922.802
1150 Woluwe-Saint-Pierre
active in Manufacture of basic pharmaceutical products (NACE 2110001)
operating since 28 Dec 1993 (≈ 33 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Analyse-Recherche-Developpement pour l'INF… shows with a free account.

See the score
Profile
SA since 1993
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result379,713 €
Equity€2.55m
Cash106,745 €
Total assets€16.3m
The line marks its sector median: 61.2% (38 companies).

Change 2022 → 2025: Equity +37 % Total assets -7 %

Accounts of the company itself (not consolidated).

The full file covers 10 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Analyse-Recherche-Developpement pour l'INF…'s annual accounts

20252024202320222021
Net result379,713 €
Equity€2.55m
Cash106,745 €
Total assets€16.3m

Filed annual accounts

  • Year ended 31 Dec 2025filed on 25 Aug 2026
  • Year ended 31 Dec 2024filed on 17 Jun 2025
  • Year ended 31 Dec 2023filed on 30 Sep 2024
  • Year ended 31 Dec 2022filed on 29 Aug 2023
  • Year ended 31 Dec 2021filed on 19 Jul 2022

Analyse-Recherche-Developpement pour l'INF…'s financial analysis

Management and control of Analyse-Recherche-Developpement pour l'INF…

2 active director(s) in the register.

Analyse-Recherche-Developpement pour l'INF…'s shareholders and holdings →

Analyse-Recherche-Developpement pour l'INF…'s publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0451.922.802
VAT number
No VAT activity declared to the CBE
Peppol
Not found on Peppol as of 10 Nov 2026 · Check
Legal form
SA
Incorporated
28 Dec 1993
Registered office
1150 Woluwe-Saint-Pierre
Latest accounts
2025 · filed on 25 Aug 2026
Activity
Manufacture of basic pharmaceutical products (NACE 2110001)

Analyse-Recherche-Developpement pour l'INF… (SA) has been based in Woluwe-Saint-Pierre since 1993, active in: manufacture of basic pharmaceutical products. For 2025, it reports a net profit of 379,713 € and equity of €2.55m; its revenue is not published.

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Analyse-Recherche-Developpement pour l'INF…

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Analyse-Recherche-Developpement pour l'INF…

What is the revenue of Analyse-Recherche-Developpement pour l'INF…?

Analyse-Recherche-Developpement pour l'INF… files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Analyse-Recherche-Developpement pour l'INF…?

According to the Crossroads Bank for Enterprises, no VAT-liable activity is declared for Analyse-Recherche-Developpement pour l'INF…. If it is VAT-registered, its VAT number is its company number prefixed with BE: BE0451922802. Its company number (CBE) is 0451.922.802.

Where is the registered office of Analyse-Recherche-Developpement pour l'INF…?

According to the CBE register, the registered office of Analyse-Recherche-Developpement pour l'INF… is in 1150 Woluwe-Saint-Pierre.

What is the equity of Analyse-Recherche-Developpement pour l'INF…?

At the close of the 2025 financial year, the equity of Analyse-Recherche-Developpement pour l'INF… amounts to 2,547,581 €, a solvency of 15.6% of total assets.

Who manages Analyse-Recherche-Developpement pour l'INF…?

The register lists 2 active mandates at Analyse-Recherche-Developpement pour l'INF…. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

How large is Analyse-Recherche-Developpement pour l'INF… within its sector?

By total assets for 2025, Analyse-Recherche-Developpement pour l'INF… ranks among the 20 largest of the 327 companies in its sector (NACE 2110) in Belgium that filed accounts for that financial year.

Idonis

The full file of Analyse-Recherche-Developpement pour l'INF…

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 27 Aug 2026

No credit card, no commitment.

What each plan unlocks →